|10.20|| -0.1601 / -1.55%|
IRIDEX Corp. develops, manufactures, and markets innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. Its ophthalmology products consist of laser systems, delivery devices and consumable instrumentation, including laser probes and are used in the treatment of serious eye diseases, including the three leading causes of irreversible blindness: diabetic retinopathy, glaucoma and age-related macular degeneration. The company's ophthalmology products are also often used in vitrectomy procedures, which are generally performed in the operating room and require a consumable single use intraocular laser probe to deliver light to the back of the eye together with other instrumentation. IRIDEX was founded by Eduardo Arias, Theodore A. Boutacoff and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.
|William M. Moore||Chairman, President & Chief Executive Officer|
|James H. Mackaness||COO, CFO & Head-Investor Relations|
|Kenneth A. Peartree||Vice President-Research & Development|
|Eduardo Arias||Senior Vice President-Global Affairs|
|Ronald T. Steckel||Vice President-Operations|